- 1、本文档共53页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
中文摘要 ···················································1
英文摘要 ···················································3
引 言 ····················································5
正 文 ····················································6
1. 研究对象 ··················································6
2. 病例选择 ··················································6
2.1 诊断标准 ·················································6
2.2 纳入标准 ·················································6
2.3 排除标准 ·················································7
2.4 剔除标准 ·················································7
3. 材料与方法 ················································7
3.1 实验材料·················································7
3.2 治疗方法 ·················································8
3.2.1 病例来源 ················································8
3.2.2 术前准备及手术方法 ······································8
3.2.3 手术遵循肿瘤根治原则 ···································9
3.2.4 手术适应症 ·············································9
3.2.5 手术禁忌证 ·············································10
3.2.6 造气腹技术 ·············································10
3.2.7 穿刺套管的放臵技术 ·····································11
3. 3 观察指标 ················································12
3.3.1 血气分析 ···············································12
3.3.2 CRP ··················································13
3.4 实验中质量控制··········································13
3.4.1 手术操作过程质量的控制 ·································13
3.4.2 实验标本采集···········································14
3.4.3 实验检测过程的质量控制·································14
3.5 统计方法 ················································14
4. 统计结果与分析 ··········································14
4. 1 各组组内比较 ············································15
4.1.1 组1组内比较 ············································15
4.1.2 组2组内比较 ············································15
4.1.3 组3组内比较 ············································16
4.2
您可能关注的文档
- CARTO系统引导下导管消融治疗老年房颤的临床疗效及安全性分析.pdf
- C-MYC基因表达在宫颈病变诊治中的应用.pdf
- CTNND2基因单核苷酸多态性与中国汉族高度近视的相关性研究.pdf
- Cyr61因子在骨肉瘤细胞中的表达和临床意义.pdf
- EZH2在正常细胞遗传学的急性髓系白血病中的表达及其与甲基转移酶基因之间的关系.pdf
- Luminal+B型乳腺癌治疗现状及生存调查.pdf
- miRNA-16在类风湿性关节炎患者血浆和关节滑液中的表达及临床意义.pdf
- MMP-9及TIMP-1在妊娠期高血压疾病患者胎盘组织中的表达及意义.pdf
- Nd和Y复合添加对AZ31镁合金组织与性能的影响.pdf
- Omi%2fHtrA2在口腔鳞癌组织中的表达及临床意义.pdf
文档评论(0)